InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Tuesday, 03/07/2017 9:57:59 PM

Tuesday, March 07, 2017 9:57:59 PM

Post# of 108192
So, for the anal cancer trial, the historical 3 year recurrence rate in similar patient populations is around 45% and 4 of the 11 living patients have passed that mark, per the corporate presentation. Let's hope the other 4 do as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News